Neil Exter - 17 Aug 2025 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role
Director
Signature
/s/ Courtney Phillips, as attorney-in-fact
Issuer symbol
MAZE
Transactions as of
17 Aug 2025
Net transactions value
$0
Form type
4
Filing time
19 Aug 2025, 16:15:35 UTC
Previous filing
30 Jan 2025
Next filing
24 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Exter Neil Director C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO /s/ Courtney Phillips, as attorney-in-fact 19 Aug 2025 0001620014

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAZE Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 17 Aug 2025 Common Stock 16,000 $13.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to 1/16th of the total award on March 3, 2025, and thereafter vested or vests as to an additional 1/16th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.